I think this stock is forming a very constructive daily chart with a classic base on base pattern that William O’Neil would approve of. I normally shy away from pharma stocks, but this chart looks very promising that I couldn’t pass it up. If we fall through gap support I would likely exit, but it held today. My first target is near $42 where I will trim some of my position.
Few other charts to watch: